Johnson & Johnson (JNJ) Cash from Financing Activities (2009 - 2026)

Johnson & Johnson has disclosed Cash from Financing Activities across 18 years of filings, most recently posting -$8.8 billion for Q2 2026.

• In Q2 2026, Cash from Financing Activities fell 54.93% year-over-year to -$8.8 billion; the TTM figure through Jun 2026 stood at -$18.5 billion (down 186.82% YoY), while the FY2025 annual figure was -$5.5 billion, down 76.85% from the prior year.
• Cash from Financing Activities came in at -$8.8 billion for Q2 2026 at Johnson & Johnson, down from $530.0 million in the prior quarter.
• In the past five years, Cash from Financing Activities ranged from a high of $10.4 billion in Q1 2025 to a low of -$11.3 billion in Q4 2023.
• Average Cash from Financing Activities over 5 years is -$2.2 billion, with a median of -$2.9 billion recorded in 2022.
• Year-over-year, Cash from Financing Activities slumped 367.53% in 2023 and soared 1808.79% in 2025.
• Over 5 years, Cash from Financing Activities stood at -$4.4 billion in 2022, then retreated by 6.16% to -$4.7 billion in 2023, then soared by 71.21% to -$1.3 billion in 2024, then fell by 2.16% to -$1.4 billion in 2025, then slumped by 541.12% to -$8.8 billion in 2026.
• Per Business Quant data, the three most recent Cash from Financing Activities figures were -$8.8 billion in Q2 2026, $530.0 million in Q1 2026, and -$1.4 billion in Q4 2025.